Belgium Insulin Industry Outlook 2022 - 2026

Key Market Indicators

Belgium's insulin exports are expected to reach 456,000 kilograms by 2026, growing at an average rate of 3.6% each year. Since 2004, the country has seen a 15.2% year-on-year increase in its supply. In 2021, Belgium was ranked 9th, with Hungary overtaking it with 368,990 kilograms. India, Italy and Germany came in 2nd, 3rd and 4th, respectively. The nation's insulin imports are estimated to hit 895,000 kilograms by 2026, with a year-on-year CAGR of 2.9%. Since 2004, Belgian demand has increased 6.7% yearly. In 2021, Iran came first with 756,190 kilograms, while Belgium was ranked 14th. France, Germany and the United Kingdom took 2nd, 3rd and 4th places respectively.

Belgium Insulin Market Data and Forecasts

Improve your Knowledge with the latest Indicators and Trends

• Insulin Market Trends: Unraveling Growth, Top Players, and Future Projections

  The insulin sector is experiencing meaningful growth, driven primarily by the increasing prevalence of diabetes globally. The extensive research and development activities in the field of diabetes management have facilitated the advent of innovative insulin delivery systems which has spurred market growth. Moreover, significant enhancements in insulin formulations in terms...

  Discover more insights

• Global Insulin Market: Comprehensive Insights into Size, Trends, and Impact Factors

  The scope of the global insulin market is primarily driven by factors like the prevalence of diabetes, technological advancements in insulin delivery systems, and the rise of obesity. The growing diabetic population across the world necessitates increased insulin production, thereby inflating the market size. Moreover, advancements in technology are facilitating...

  Discover more insights

• Deep-Dive into the Diverse Insulin Market: Key Products, Diabetes Types, and Segmentation Insights

  The Insulin market is populated with an array of products categorized mainly into basal, rapid-acting, traditional, and premixed insulins. Basal and rapid-acting insulin products, such as insulin glargine and insulin lispro, maintain a dominant presence due to their critical role in diabetes management. Traditional human insulins, despite their lower cost,...

  Discover more insights

• Diabetes Care: Navigating Insulin Delivery Trends - Pumps, Syringes, Pens and Modern Innovations

  Conventional methods for insulin delivery, primarily syringes and insulin pens, have been undergoing substantial enhancements. Syringes, although more cost-effective, lack the convenience and precision offered by pens. Insulin pens, on the other hand, have been evolved to offer enhanced ease-of-use, enabling patients to self-administer insulin with more flexibility, catering to...

  Discover more insights

• Insulin Markets: Comparative Examination for Key Global Regions

  The world insulin market shows considerable variation across different geographical regions. The industrialized countries, primarily North America and Europe, continue to dominate in both production and consumption. The U.S. alone accounts for a substantial share of the global insulin market, driven by a large patient population and technological advancements. Europe...

  Discover more insights